PetIQ Inc. (PETQ) PT Raised to $41 at Raymond James
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
PetIQ, Inc. Reports Record Fourth Quarter and Full Year 2018 Financial Results
March 11, 2019 4:05 PM EDTFourth Quarter 2018 Net Sales Increased 114% Year-Over-Year to $111.0 Million Full Year 2018 Net Sales of $528.6 Million Provides Full Year 2019 Outlook
EAGLE, Idaho, March 11, 2019 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three months and full year ended December 31, 2018.
Fourth Quarter 2018 Highlights Compared to Prior Year Period
Record fourth quarter net sales of $111.0 million, an increase of 114%;Â representing organic net sales growth of 70%Net loss of... More